Dr. Bala Manian
Dr. Manian is the current chairman of EPPIC. A serial enterprenuer,
he has founded of a long list of biotechnology and instrumentation companies
including Biometric Imaging Inc, Surromed, QDOT, Entigen, Biometric imaging,
Lumisys, Molecular Dynamics, and Digital Optics Corp.
Presently Dr. Manian is involved with Surromed, Q DOT Corporation, and Entigen. Previosly he was the
founder-chairman of Biometric
Imaging Inc, a systems company dedicated to advancing cellular therapeutics, which has
since been acquired by medical
device giant Becton Dickinson & Co. Prior to founding Biometric Imaging, Dr. Manian
founded both Lumisys and Molecular Dynamics in 1987.
Lumisys manufactures and markets Tele-radiology systems to the medical imaging market.
Molecular Dynamics, manufactures and markets analytical
instrumentation systems to molecular biology and genetic engineering research. Both
Lumisys (LUMI) and Molecular Dynamics (MDYN) went public on the NASDAQ before their
acquisition by Eastman Kodak and Amersham Pharmacia Biotech, respectively. Dr.
Manian founded Digital Optics Corp
in 1980, an optical instrumentation and systems development company that was acquired by
Matrix Corp in 1984.
An expert in the design of electro-optical systems, Dr. Manian holds more than 30 patents,
many of which have resulted in successful commercial products. Additionally, Dr. Manian
has authored more than 35 scientific publications. He has a B.S. in Physics from the
University of Madras, an M.S in Applied Optics from the University of Rochester, and a
Ph.D in Mechanical Engineering from Purdue Universiy. He has been a Faculty Member at the
University of Rochester's Institute of Optics for four years, teaching courses in optical
fabrication and testing, optical instrumentation and holography. Dr. Manian left the
institute in 1974 to pursue commercial opportunities.
Dr. Manian has been recognized by the award of an "Academy Certificate"
from the Academy of Motion Picture Arts and Sciences for inventing the special effects technology used in movies like
"Return of the Jedi" and the Indiana Jones Trilogy. The technology
developed by Bala Manian, David DiFrancesco and Thomas Noggle, at Digital Optics Corp.,
and transferred to Lucas film Ltd. in 1983, allowed filmmakers to insert special effects
into movies using computerized digital imaging. This was a considerable improvement
over existing technology, which involved an expensive and painstaking procedure whereby
two different sets of images, almost two movies, had to be created and combined to achieve
the same special effects.
A Co-Founder and
Business Development Director of Triesta Sciences,
Gans has nearly 15 years of venture development, business management and
M&A experience in the life sciences and technology industries whilst at CSFB in
New York and the West Coast and at Tata Industries Limited in India.
As President and Chief Executive Officer of Bioimagene,
Mohan is responsible for the companyís strategic direction and
day-to-day operations. Prior to co-founding BioImagene, Mohan was cofounder
of Roamware Inc and was president and founder of SoftPlus, a leading
provider of eCRM software for telecom carriers around the world. In February
2000, SoftPlus was sold to US Interactive for $360 million. Prior to that,
Mohan co-founded and served as president of Digital Tools, Inc., a leader in
enterprise project and resource management software. Before Digital Tools he
held various software development and management positions with Hewlett
Packard and Intel. Mohan has more than 20 years of experience as a high-tech
executive and entrepreneur.
Mohan earned a masterís degree of science in computer science from the
Florida Institute of Technology, and a masterís degree of science in
electrical engineering from Bombay, India. He has participated in several
executive management programs at Stanford University and is a charter member
of TiE (The Indus Entrepreneurs), the Silicon Valley-based forum for
Chahda is currently Senior Managing Director of WestBridge Partners.
Prior to founding WestBridge, Sumir was a key member of the Principal
Investment Area at Goldman, Sachs & Co, based in New York and Singapore, focused
on venture investments in technology. He led or was a key member of the
investment team for over 17 technology companies including high profile success
stories such as Storage Networks (NASDAQ: STOR), FreeMarkets (NASDAQ: FMKT),
webMethods (NASDAQ: WEBM), Centra (NASDAQ: CTRA), Ventro/Chemdex (NASDAQ: VNTR)
and TechSpan. These investments totaled over $140 million of private equity
career began as a management consultant at McKinsey & Co. based in New York and
New Delhi, where he specialized in the Internet and wireless industries.
Sumir is the Chairman of the US-India Venture Capital Association and
also a Charter Member of The Indus Entrepreneurs (TiE)'s Silicon Valley chapter.
Sumir received an MBA with distinction from Harvard
University and a BSE in Computer Science from Princeton University
Rajiv P. Patel
Patel is a Partner at Fenwick and
West, as part of the Intellectual Property Group.
He represents companies from privately held start-ups to publicly traded
corporations on a wide variety of complex intellectual property issues and
matters. Mr. Patel counsels companies on patent portfolio development and
management strategies, patent enforcement strategies, and patent and high
technology licensing agreements, and strategies. Mr. Patel also leads
intellectual property audits to help companies identify key intellectual assets
and evaluate protection options for such assets.
Mr. Patel has legal, technical, and business experience
representing companies in high technology areas that include wireless
communications, electronics, complex computer hardware architecture, complex
software architecture, electro-mechanical devices, and nanotechnology
applications. Mr. Patel also has legal, technical and business experience
representing technology think-tanks and traditional non-technology companies for
patent and other intellectual property matters.
Pias is a Partner at Fenwick and West, as part of the
Intellectual Property Group. Mr. Pais'
practice is in the broad area of technology-related transactions, including
licensing, technology development agreements, strategic alliances and
distribution agreements. In addition, he works on the intellectual property
aspects of significant corporate transactions such as mergers, acquisitions and
spin-outs. In his practice, Mr. Pais represents clients across the broad
spectrum of Silicon Valley business activities, including semiconductor
manufacturing design and related tools, equipment and design software, online
service providers and market places, enterprise and consumer software products,
life sciences and health care. In addition, Mr. Pais is responsible for leading
the firm's international practice activities and he has extensive experience
assisting U.S. companies expanding their business activities in other parts of
the world, and representing non-U.S. entities establishing activities in Silicon